Abstract
Fifty-two of 298 children vaccinated with the measles-mumps-rubella (MMR) vaccine at around the age of 16 months were evaluated for antibody titres against measles, mumps, and rubella. The seropositivity rates for measles, mumps, and rubella were 86%, 92%, and 98%, respectively. While the most prominent side effects were irritability (6.04%) and fever (4.69%), 83.55% of the vaccinated children showed no undesirable reaction to the vaccine. The MMR vaccine appeared to be immunogenic and nonreactogenic for the children in the study.
How to cite
1.
Topal B, Kanra G, Ceyhan M. Serological evaluation of 52 children immunized with the combined measles, mumps and rubella vaccine. Turk J Pediatr 1991; 33: 13-18.